CSS LLC’s Flexion Therapeutics, Inc. FLXN Stock Holding History

CSS LLC’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-25,800	Closed	-$521K	–	676
2017 Q2	$521K	Buy	+25,800	New	+$537K	0.03%	348

Other funds holding FLXN

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

CSS LLC's FLXN Position: Q1 2018 in Review

CSS LLC sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2018, closing a stake of 4,680 shares — an estimated $117K sold.

CSS LLC first reported a position in FLXN in Q4 2017 and held it in 1 quarter. The position peaked at $117K in Q4 2017. 134 funds tracked by Wall St. Rank hold FLXN as of Q1 2018.

CSS LLC reported no remaining Flexion Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
CSS LLC sold 4,680 Flexion Therapeutics, Inc. shares in Q1 2018, an estimated $117K.
CSS LLC first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
CSS LLC's Flexion Therapeutics, Inc. position peaked at $117K in Q4 2017.
134 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2018.

Based on CSS LLC's 13F filing for Q1 2018, filed 15 May 2018.